Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 2/2018

10.08.2017 | Original Contribution

Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in autism

verfasst von: Li Wang, Yu-Mei Yu, You-qi Zhang, Jie Zhang, Na Lu, Na Liu

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to assess the prevalence of small intestinal bacterial overgrowth (SIBO) by hydrogen breath test in patients with autism spectrum disorders (ASD) with respect to a consistent control group. From 2011 to 2013, 310 children with ASD and 1240 sex- and age-matched typical children were enrolled in this study to undergo glucose breath test. The study participants were considered to exhibit SIBO when an increase in H2 of ≥20 ppm or CH4 of ≥10 ppm with respect to the fasting value was observed up to 60 min after the ingestion of glucose. Ninety-six children with autism suffered from SIBO, giving a prevalence rate of SIBO was 31.0% (95% CI 25.8–36.1%). In contrast, 9.3% of the typical children acknowledged SIBO. The difference between groups was statistically significant (P < 0.0001). The median Autism Treatment Evaluation Checklist (ATEC) score in the children with autism and with SIBO was significantly high when compared with the children without autism and without SIBO [98 (IQR, 45–120) vs. 63 (32–94), P < 0.001]. For the autism group, the 6-GI Severity Index (6-GSI) score was found to be strongly and significantly correlated with the total ATEC score (r = 0.639, P < 0.0001). SIBO was significantly associated with worse symptoms of autism, demonstrating that children with SIBO may significantly contribute to symptoms of autism.
Literatur
1.
Zurück zum Zitat Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C (2013) Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 346:f2059CrossRefPubMedPubMedCentral Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C (2013) Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 346:f2059CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Tu W, Yin C, Guo Y, Li SO, Chen H, Zhang Y, Feng YL, Long BH (2013) Serum homocysteine concentrations in Chinese children with autism. Clin Chem Lab Med 51(2):e19–e22CrossRefPubMed Tu W, Yin C, Guo Y, Li SO, Chen H, Zhang Y, Feng YL, Long BH (2013) Serum homocysteine concentrations in Chinese children with autism. Clin Chem Lab Med 51(2):e19–e22CrossRefPubMed
3.
Zurück zum Zitat Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8(7):e68322CrossRefPubMedPubMedCentral Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8(7):e68322CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D (2015) Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138:179–187CrossRefPubMed Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D (2015) Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138:179–187CrossRefPubMed
5.
Zurück zum Zitat de Theije CGM, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R (2014) Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37:197–206CrossRefPubMed de Theije CGM, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R (2014) Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37:197–206CrossRefPubMed
6.
Zurück zum Zitat Gondalia SV, Palombo EA, Knowles SR, Cox SB, Meyer D, Austin DW (2012) Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 5(6):419–427CrossRefPubMed Gondalia SV, Palombo EA, Knowles SR, Cox SB, Meyer D, Austin DW (2012) Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 5(6):419–427CrossRefPubMed
7.
Zurück zum Zitat Donowitz JR, Petri WA (2015) Pediatric small intestine bacterial overgrowth in low-income countries. Trends Mol Med 21(1):6–15CrossRefPubMed Donowitz JR, Petri WA (2015) Pediatric small intestine bacterial overgrowth in low-income countries. Trends Mol Med 21(1):6–15CrossRefPubMed
8.
Zurück zum Zitat Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gasbarrini G, Gasbarrini A (2005) Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome. Aliment Pharmacol Ther 22(11–12):1157–1160CrossRefPubMed Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gasbarrini G, Gasbarrini A (2005) Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome. Aliment Pharmacol Ther 22(11–12):1157–1160CrossRefPubMed
9.
Zurück zum Zitat Tan AH, Mahadeva S, Thalha AM, Gibson PR, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Tan CT, Yong HS, Marras C, Fox SH, Lim SY (2014) Small intestinal bacterial overgrowth in Parkinson’s disease. Parkinsonism Relat Disord 20(5):535–540CrossRefPubMed Tan AH, Mahadeva S, Thalha AM, Gibson PR, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Tan CT, Yong HS, Marras C, Fox SH, Lim SY (2014) Small intestinal bacterial overgrowth in Parkinson’s disease. Parkinsonism Relat Disord 20(5):535–540CrossRefPubMed
10.
Zurück zum Zitat Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2):577–594CrossRefPubMed Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2):577–594CrossRefPubMed
11.
Zurück zum Zitat Fialho A, Fialho A, Schenone A, Thota P, McCullough A, Shen B (2016) Association between small intestinal bacterial overgrowth and deep vein thrombosis. Gastroenterol Rep 4(4):299–303CrossRef Fialho A, Fialho A, Schenone A, Thota P, McCullough A, Shen B (2016) Association between small intestinal bacterial overgrowth and deep vein thrombosis. Gastroenterol Rep 4(4):299–303CrossRef
12.
Zurück zum Zitat Geier DA, Kern JK, Geier MR (2013) A comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the quantitative evaluation of autism. J Mental Health Res Intell Disabil 6(4):255–267CrossRef Geier DA, Kern JK, Geier MR (2013) A comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the quantitative evaluation of autism. J Mental Health Res Intell Disabil 6(4):255–267CrossRef
13.
Zurück zum Zitat Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712CrossRefPubMed Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712CrossRefPubMed
14.
Zurück zum Zitat Leiby A, Mehta D, Gopalareddy V, Jackson-Walker S, Horvath K (2010) Bacterial overgrowth and methane production in children with encopresis. J Pediatr 156:766–770CrossRefPubMed Leiby A, Mehta D, Gopalareddy V, Jackson-Walker S, Horvath K (2010) Bacterial overgrowth and methane production in children with encopresis. J Pediatr 156:766–770CrossRefPubMed
15.
Zurück zum Zitat Parracho HMRT, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54(10):987–991CrossRefPubMed Parracho HMRT, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54(10):987–991CrossRefPubMed
16.
Zurück zum Zitat de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51(4):418–424CrossRefPubMed de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51(4):418–424CrossRefPubMed
17.
Zurück zum Zitat Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4):444–453CrossRefPubMed Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4):444–453CrossRefPubMed
18.
Zurück zum Zitat Finegold SM, Summanen PH, Downes J (2017) Detection of Clostridium perfringens toxin genes in the gut microbiota of autistic children. Anaerobe 45:133–137CrossRefPubMed Finegold SM, Summanen PH, Downes J (2017) Detection of Clostridium perfringens toxin genes in the gut microbiota of autistic children. Anaerobe 45:133–137CrossRefPubMed
19.
Zurück zum Zitat Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC gastroenterology 11(1):1CrossRef Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC gastroenterology 11(1):1CrossRef
20.
Zurück zum Zitat Mello CS, Tahan S, Melli LC, Rodrigues MS, de Mello RM, Scaletsky IC, de Morais MB (2012) Methane production and small intestinal bacterial overgrowth in children living in a slum. World J Gastroenterol 18:5932–5939CrossRefPubMedPubMedCentral Mello CS, Tahan S, Melli LC, Rodrigues MS, de Mello RM, Scaletsky IC, de Morais MB (2012) Methane production and small intestinal bacterial overgrowth in children living in a slum. World J Gastroenterol 18:5932–5939CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat dos Reis JC, de Morais MB, Oliva CA, Fagundes-Neto U (2007) Breath hydrogen test in the diagnosis of environmental enteropathy in children living in an urban slum. Dig Dis Sci 52:1253–1258CrossRefPubMed dos Reis JC, de Morais MB, Oliva CA, Fagundes-Neto U (2007) Breath hydrogen test in the diagnosis of environmental enteropathy in children living in an urban slum. Dig Dis Sci 52:1253–1258CrossRefPubMed
22.
Zurück zum Zitat Pereira SP, Khin-Maung-U TD, Duncombe VM, Nyunt- Nyunt-Wai JM (1991) A pattern of breath hydrogen excretion suggesting small bowel bacterial overgrowth in Burmese village children. J Pediatr Gastroenterol Nutr 13:32–38CrossRefPubMed Pereira SP, Khin-Maung-U TD, Duncombe VM, Nyunt- Nyunt-Wai JM (1991) A pattern of breath hydrogen excretion suggesting small bowel bacterial overgrowth in Burmese village children. J Pediatr Gastroenterol Nutr 13:32–38CrossRefPubMed
23.
Zurück zum Zitat Molloy CA, Manning-Courtney P (2003) Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 7(2):165–171CrossRefPubMed Molloy CA, Manning-Courtney P (2003) Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 7(2):165–171CrossRefPubMed
24.
Zurück zum Zitat Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold EL, Shah B, Posey DJ, Ritz L, Scahill L (2009) Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord 39:405–413CrossRefPubMed Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold EL, Shah B, Posey DJ, Ritz L, Scahill L (2009) Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord 39:405–413CrossRefPubMed
25.
Zurück zum Zitat Ming X, Brimacombe M, Chaaban J, Zimmerman-Bier B, Wagner GC (2008) Autism spectrum disorders: concurrent clinical disorders. J Child Neurol 23(1):6–13CrossRef Ming X, Brimacombe M, Chaaban J, Zimmerman-Bier B, Wagner GC (2008) Autism spectrum disorders: concurrent clinical disorders. J Child Neurol 23(1):6–13CrossRef
26.
Zurück zum Zitat Adams JB, Holloway CE, George F, Quig D (2006) Analyses of toxic metals and essential minerals in the hair of arizona children with autism and their mothers. Biol Tr El Res 110:193–209CrossRef Adams JB, Holloway CE, George F, Quig D (2006) Analyses of toxic metals and essential minerals in the hair of arizona children with autism and their mothers. Biol Tr El Res 110:193–209CrossRef
27.
Zurück zum Zitat Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, Veenstra-VanderWeele J, Anderson GM, Savidge T, Williams KC (2017) Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cell Mol Gastroenterol Hepatol 3(2):218–230CrossRefPubMed Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, Veenstra-VanderWeele J, Anderson GM, Savidge T, Williams KC (2017) Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cell Mol Gastroenterol Hepatol 3(2):218–230CrossRefPubMed
28.
Zurück zum Zitat Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, Nelson MN, Wexler HM (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15(7):429–435CrossRefPubMed Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, Nelson MN, Wexler HM (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15(7):429–435CrossRefPubMed
29.
Zurück zum Zitat MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176(1):149–169CrossRefPubMed MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176(1):149–169CrossRefPubMed
30.
Zurück zum Zitat Louis P (2012) Does the human gut microbiota contribute to the etiology of autism spectrum disorders? Dig Dis Sci 57(8):1987–1989CrossRefPubMed Louis P (2012) Does the human gut microbiota contribute to the etiology of autism spectrum disorders? Dig Dis Sci 57(8):1987–1989CrossRefPubMed
31.
Zurück zum Zitat Critchfield JW, Van Hemert S, Ash M, Mulder L, Ashwood P (2011) The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011(2011):161358-1–161358-8. doi:10.1155/2011/161358 Critchfield JW, Van Hemert S, Ash M, Mulder L, Ashwood P (2011) The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011(2011):161358-1–161358-8. doi:10.​1155/​2011/​161358
32.
Zurück zum Zitat Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC (2016) Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS One 11(1):e0146797CrossRefPubMedPubMedCentral Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC (2016) Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS One 11(1):e0146797CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Khalighi AR, Khalighi MR, Behdani R, Jamali J, Khosravi A, Kouhestani Sh, Radmanesh H, Esmaeelzadeh S, Khalighi N (2014) Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)—a pilot study. Indian J Med Res 140(5):604–608PubMedPubMedCentral Khalighi AR, Khalighi MR, Behdani R, Jamali J, Khosravi A, Kouhestani Sh, Radmanesh H, Esmaeelzadeh S, Khalighi N (2014) Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)—a pilot study. Indian J Med Res 140(5):604–608PubMedPubMedCentral
34.
Zurück zum Zitat Adams JB, Romdalvik J, Levine KE, Hu LW (2008) Mercury in first-cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 90:739–753CrossRef Adams JB, Romdalvik J, Levine KE, Hu LW (2008) Mercury in first-cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 90:739–753CrossRef
35.
Zurück zum Zitat Zhu YG, Carvey PM, Ling ZD (2007) Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int 50:671–680CrossRefPubMedPubMedCentral Zhu YG, Carvey PM, Ling ZD (2007) Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int 50:671–680CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, Pollard EL, Roux S, Sadowsky MJ, Lipson KS, Sullivan MB, Caporaso JG, Krajmalnik-Brown R (2017) Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5(1):10CrossRefPubMedPubMedCentral Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, Pollard EL, Roux S, Sadowsky MJ, Lipson KS, Sullivan MB, Caporaso JG, Krajmalnik-Brown R (2017) Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5(1):10CrossRefPubMedPubMedCentral
37.
38.
Zurück zum Zitat Niu XL, Liu L, Song ZX, Li Q, Wang ZH, Zhang JL, Li HH (2016) Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson’s disease. J Neural Transm 123(12):1381–1386CrossRefPubMed Niu XL, Liu L, Song ZX, Li Q, Wang ZH, Zhang JL, Li HH (2016) Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson’s disease. J Neural Transm 123(12):1381–1386CrossRefPubMed
Metadaten
Titel
Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in autism
verfasst von
Li Wang
Yu-Mei Yu
You-qi Zhang
Jie Zhang
Na Lu
Na Liu
Publikationsdatum
10.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 2/2018
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-017-1039-2

Weitere Artikel der Ausgabe 2/2018

European Child & Adolescent Psychiatry 2/2018 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.